• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Debasish Roychowdhury - Articles and news items

Sanofi

Curie-Cancer and Sanofi cooperate in research on ovarian cancer

Industry news, News / 19 June 2013 / Sanofi

Preclinical program of translational research to identify new target proteins…

Sanofi

ZALTRAP® (aflibercept) approved in the EU

Industry news, News / 5 February 2013 / Sanofi

First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen…

Sanofi

Phase II Trial of Sanofi JAK2 inhibitor in myelofibrosis met primary endpoint

Industry news, News / 9 December 2012 / Sanofi

New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation…

Sanofi

Sanofi compounds to be featured in 178 abstracts at American Society of Hematology Annual Meeting

Industry news, News / 3 December 2012 / Sanofi

American Society of Hematology, Atlanta, GA., 8-11 December, 2012…

Sanofi

ZALTRAP® receives CHMP positive opinion in the European Union for previously treated mCRC

Industry news, News / 16 November 2012 / Sanofi

“We are pleased that CHMP has supported our ZALTRAP application…”

SANOFI logo

Journal of Clinical Oncology publishes Phase III results of ZALTRAP® (aflibercept) VELOUR study

Industry news, News / 8 October 2012 / Sanofi

Results from the pivotal Phase III VELOUR study…

SANOFI logo

ASCO abstracts highlight late-stage Sanofi Oncology pipeline

Industry news, News / 16 May 2012 / Sanofi

Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured…

SANOFI logo

Sanofi and Regeneron announce regulatory and clinical update for Zaltrap® (aflibercept)

Industry news, News / 5 April 2012 / Sanofi

The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®…

SANOFI logo

New data in breast and ovarian cancer presented at ASCO support continued development of Iniparib

Industry news, News / 6 June 2011 / Sanofi

Sanofi announced new data for iniparib (BSI-201)…

SANOFI logo

ZALTRAP™ (aflibercept) significantly improved survival in previously treated metastatic colorectal cancer patients

Industry news, News / 6 June 2011 / Sanofi

Data will be presented at the ESMO World Congress on Gastrointestinal Cancer…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +